Clinical trial
Treatment of Latent Tuberculosis Infection With Isoniazid
NCT00293228 · Instituto Nacional de Salud Publica, Mexico, Other · Completed
Key facts
| NCT number | NCT00293228 |
|---|---|
| Title | Treatment of Latent Tuberculosis Infection With Isoniazid |
| Official title | Drugs for Treatment of Latent Tuberculosis Infection Objective 4: Identify Biomarkers for Clinical Trials of Drugs Active Against Latent TB |
| Lead sponsor | Instituto Nacional de Salud Publica, Mexico, Other |
| Collaborators | Bill and Melinda Gates Foundation Wellcome Trust |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tuberculosis |
| Intervention type | Drug |
| Interventions | Isoniazid, isoniazid |
| Enrollment | 200 |
| Start date | Feb 1, 2007 |
| Primary completion | Mar 1, 2008 |
| Completion | Jun 1, 2009 |
| First posted | Feb 17, 2006 |
| Last update posted | May 26, 2010 |
| Countries | Mexico |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: